Top Stories

GOP strategist Karl Rove has criticized U.S. President-elect Donald Trump's comments on aircraft maker Boeing Co.'s (BA) contract for a new Air Force One plane, saying they were inaccurate and de-stabled the stock of a major company. Air Force One is...


Consumer sentiment in the U.S. has improved by much more than anticipated in the month of December, according to a report released by the University of Michigan on Friday. The University of Michigan said the preliminary reading on its consumer sentiment...


With a deadline to avoid a government shutdown looming, the House voted Thursday to approve a short-term government spending bill. The House voted 326 to 96 in favor of the continuing resolution, which funds the government at current levels through...


Stocks remain mostly positive in mid-day trading on Friday after moving to the upside earlier in the session. With the gains on the day, all three of the major averages have once again reached new record highs.

KirstenGillibrand-120216.jpg Senator Kirsten Gillibrand, D-N.Y., has indicated she plans to oppose a waiver required for retired Marine Corps General James Mattis to serve as President-elect Donald Trump's Defense Secretary. As Mattis retired from the military in 2013, his nomination...
LuisVicente-120216.jpg Claiming President-elect Donald Trump continues to "spew hatred, bigotry and prejudice," Democratic Congressman Luis Gutierrez, D-Ill., said he intends to boycott the presidential inauguration in January. Gutierrez told CNN's "New Day" on Friday he...
USCapitol-120316.jpg A $618.7 billion defense policy bill easily cleared the House with bipartisan support on Friday and now heads to the Senate. The House voted 375 to 34 in favor of the National Defense Authorization Act, with four Republicans and thirty Democrats voting against the bill.
wallstreet1-103112_02Dec16.jpg Following the mixed performance seen in the previous session, stocks showed a lack of direction over the course of the trading session on Friday. The major averages spent the day bouncing back and forth across the unchanged line before roughly flat.
AlanMulally-120916.jpg A long list of potential nominees for Secretary of State under President-elect Donald Trump has widened to include former Ford (F) CEO Alan Mulally. Trump senior adviser Kellyanne Conway revealed that Mulally is under consideration to be the nation's top diplomat in an interview on Fox News on Friday.
CapitolBuilding-120816.jpg With a deadline to avoid a government shutdown looming, the House voted Thursday to approve a short-term government spending bill. The House voted 326 to 96 in favor of the continuing resolution, which funds the government at current levels through April 28th.
China-CPI-PPI-120916.jpgChina's factory gate inflation increased to a more than five-year high in November on higher commodity prices and consumer price inflation exceeded expectations due to rising food costs. Producer price inflation accelerated notably to 3.3 percent from 1.2 percent in the previous month, the National Bureau of Statistics showed Friday. Inflation was expected to rise to 2.3 percent.
Older adults who suffer from dementia, or mild cognitive impairment, may benefit from aerobic exercise, according to a new study. The study, to be presented Wednesday at the Radiological Society of North America, included 16 people with an average age of 63, who did aerobic workouts on a treadmill, stationary bike or elliptical training. They worked out four times a week for six months.
The Swiss stock market ended Friday's session with a sharp increase, extending its winning streak to five sessions. The market broke out past the 8,100 point level at its intraday high, its highest level since mid-October. The strong performance of the pharmaceutical stocks drove the market higher. The...
Harry Potter and the Cursed Child is the best-selling book of 2016 overall and in the Kids & Teens category, confirming the ongoing demand for Harry Potter, Amazon announced. The book, by J.K. Rowling, Jack Thorne and John Tiffany, is also this year's Most Wished For and Most Gifted book.
Talks are gaining ground that the anti-regulation mindset of president-elect Donald Trump may not spare even the FDA. The first 100 days action plan released by Trump in late October suggested that he may seek to cut the red tape at the FDA, ensuring expedited drug approval processes. More
AstraZeneca (AZN.L, AZN) and its global biologics research and development arm, MedImmune, announced that the US Food and Drug Administration has accepted the first Biologics License Application or BLA for durvalumab, a PD-L1 human monoclonal antibody... More
new-Super-Mario-120816.jpg Super Mario Run, a new game that would offer augmented reality game experience on iPhones and androids will be launched soon. The video game developed by Nintendo will be available from December 15 on iOS and a few months later in Androids. The new game will be side scrolling, and will work on auto runner platform. Mario, the video game character, is a jump man. It was created by Shigeru Miyamoto
Follow RTT
Economic Calendar
12/09/16 10:30CB Coincidence IndexOCT South Korea
12/09/16 10:30CB Leading IndexOCT South Korea
12/09/16 10:0Inventories (M-o-M)OCT United States
12/09/16 10:0Inventories (Y-o-Y)OCT United States
12/09/16 10:0Wholesale Sales (M-o-M)OCT United States
12/09/16 10:0Wholesale Sales (Y-o-Y)OCT United States
Complete Economic Calendar
FDA Calendar
Event DateSymbolDrug NameEvent Name
03/02/17BMYOpdivo (sBLA)FDA decision on Opdivo for patients with locally advanced unresectable or metastatic urothelial carcinoma that has progressed on or after platinum-containing therapy
02/28/17LXRXTelotristat Etiprate (NDA)FDA decision on Telotristat Etiprate for the treatment of carcinoid syndrome
02/23/17CLVSRucaparib (NDA)FDA decision on Rucaparib for the treatment of advanced mutant BRCA ovarian cancer.
02/17/17GMXAY.PK, GNMSF.OBDARZALEX in combination with lenalidomide and dexamethasone, or bortezomib and dexamethasone (sBLA)FDA decision on DARZALEX combination for relapsed multiple myeloma
02/16/17NBIXINGREZZA (NDA)FDA panel to review INGREZZA for tardive dyskinesia
Complete FDA Calendar